Functional significance of Hippo/YAP signaling for drug resistance in colorectal cancer

Ruolan Song, Dongsheng Gu, Lining Zhang, Xiaoli Zhang, Beiqin Yu, Bingya Liu, Jingwu Xie

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Colorectal cancer is a leading cause of cancer-related death worldwide. While early stage colorectal cancer can be removed by surgery, patients with advanced disease are treated by chemotherapy, with 5-Fluorouracil (5-FU) as a main ingredient. However, most patients with advanced colorectal cancer eventually succumb to the disease despite some responded initially. Thus, identifying molecular mechanisms responsible for drug resistance will help design novel strategies to treat colorectal cancer. In this study, we analyzed an acquired 5-FU resistant cell line, LoVo-R, and determined that elevated expression of YAP target genes is a major alteration in the 5-FU resistant cells. Hippo/YAP signaling, a pathway essential for cell polarity, is an important regulator for tissue homeostasis, organ size, and stem cells. We demonstrated that knockdown of YAP1 sensitized LoVo-R cells to 5-FU treatment in cultured cells and in mice. The relevance of our studies to colorectal cancer patients is reflected by our discovery that high expression of YAP target genes in the tumor was associated with an increased risk of cancer relapse and poor survival in a larger cohort of colorectal cancer patients who underwent 5-FU-related chemotherapy. Taken together, we demonstrate a critical role of YAP signaling for drug resistance in colorectal cancer.

Original languageEnglish (US)
JournalMolecular Carcinogenesis
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Drug Resistance
Colorectal Neoplasms
Fluorouracil
Drug Therapy
Neoplasms
Cell Polarity
Organ Size
Genes
Cultured Cells
Homeostasis
Stem Cells
Recurrence
Cell Line
Survival

Keywords

  • 5-fluorouracil (5-FU)
  • cancer therapy
  • colorectal cancer
  • drug resistance
  • YAP

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this

Functional significance of Hippo/YAP signaling for drug resistance in colorectal cancer. / Song, Ruolan; Gu, Dongsheng; Zhang, Lining; Zhang, Xiaoli; Yu, Beiqin; Liu, Bingya; Xie, Jingwu.

In: Molecular Carcinogenesis, 01.01.2018.

Research output: Contribution to journalArticle

Song, Ruolan ; Gu, Dongsheng ; Zhang, Lining ; Zhang, Xiaoli ; Yu, Beiqin ; Liu, Bingya ; Xie, Jingwu. / Functional significance of Hippo/YAP signaling for drug resistance in colorectal cancer. In: Molecular Carcinogenesis. 2018.
@article{d57bdffa10384dadadbf38024723054c,
title = "Functional significance of Hippo/YAP signaling for drug resistance in colorectal cancer",
abstract = "Colorectal cancer is a leading cause of cancer-related death worldwide. While early stage colorectal cancer can be removed by surgery, patients with advanced disease are treated by chemotherapy, with 5-Fluorouracil (5-FU) as a main ingredient. However, most patients with advanced colorectal cancer eventually succumb to the disease despite some responded initially. Thus, identifying molecular mechanisms responsible for drug resistance will help design novel strategies to treat colorectal cancer. In this study, we analyzed an acquired 5-FU resistant cell line, LoVo-R, and determined that elevated expression of YAP target genes is a major alteration in the 5-FU resistant cells. Hippo/YAP signaling, a pathway essential for cell polarity, is an important regulator for tissue homeostasis, organ size, and stem cells. We demonstrated that knockdown of YAP1 sensitized LoVo-R cells to 5-FU treatment in cultured cells and in mice. The relevance of our studies to colorectal cancer patients is reflected by our discovery that high expression of YAP target genes in the tumor was associated with an increased risk of cancer relapse and poor survival in a larger cohort of colorectal cancer patients who underwent 5-FU-related chemotherapy. Taken together, we demonstrate a critical role of YAP signaling for drug resistance in colorectal cancer.",
keywords = "5-fluorouracil (5-FU), cancer therapy, colorectal cancer, drug resistance, YAP",
author = "Ruolan Song and Dongsheng Gu and Lining Zhang and Xiaoli Zhang and Beiqin Yu and Bingya Liu and Jingwu Xie",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/mc.22883",
language = "English (US)",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Functional significance of Hippo/YAP signaling for drug resistance in colorectal cancer

AU - Song, Ruolan

AU - Gu, Dongsheng

AU - Zhang, Lining

AU - Zhang, Xiaoli

AU - Yu, Beiqin

AU - Liu, Bingya

AU - Xie, Jingwu

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Colorectal cancer is a leading cause of cancer-related death worldwide. While early stage colorectal cancer can be removed by surgery, patients with advanced disease are treated by chemotherapy, with 5-Fluorouracil (5-FU) as a main ingredient. However, most patients with advanced colorectal cancer eventually succumb to the disease despite some responded initially. Thus, identifying molecular mechanisms responsible for drug resistance will help design novel strategies to treat colorectal cancer. In this study, we analyzed an acquired 5-FU resistant cell line, LoVo-R, and determined that elevated expression of YAP target genes is a major alteration in the 5-FU resistant cells. Hippo/YAP signaling, a pathway essential for cell polarity, is an important regulator for tissue homeostasis, organ size, and stem cells. We demonstrated that knockdown of YAP1 sensitized LoVo-R cells to 5-FU treatment in cultured cells and in mice. The relevance of our studies to colorectal cancer patients is reflected by our discovery that high expression of YAP target genes in the tumor was associated with an increased risk of cancer relapse and poor survival in a larger cohort of colorectal cancer patients who underwent 5-FU-related chemotherapy. Taken together, we demonstrate a critical role of YAP signaling for drug resistance in colorectal cancer.

AB - Colorectal cancer is a leading cause of cancer-related death worldwide. While early stage colorectal cancer can be removed by surgery, patients with advanced disease are treated by chemotherapy, with 5-Fluorouracil (5-FU) as a main ingredient. However, most patients with advanced colorectal cancer eventually succumb to the disease despite some responded initially. Thus, identifying molecular mechanisms responsible for drug resistance will help design novel strategies to treat colorectal cancer. In this study, we analyzed an acquired 5-FU resistant cell line, LoVo-R, and determined that elevated expression of YAP target genes is a major alteration in the 5-FU resistant cells. Hippo/YAP signaling, a pathway essential for cell polarity, is an important regulator for tissue homeostasis, organ size, and stem cells. We demonstrated that knockdown of YAP1 sensitized LoVo-R cells to 5-FU treatment in cultured cells and in mice. The relevance of our studies to colorectal cancer patients is reflected by our discovery that high expression of YAP target genes in the tumor was associated with an increased risk of cancer relapse and poor survival in a larger cohort of colorectal cancer patients who underwent 5-FU-related chemotherapy. Taken together, we demonstrate a critical role of YAP signaling for drug resistance in colorectal cancer.

KW - 5-fluorouracil (5-FU)

KW - cancer therapy

KW - colorectal cancer

KW - drug resistance

KW - YAP

UR - http://www.scopus.com/inward/record.url?scp=85052432152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052432152&partnerID=8YFLogxK

U2 - 10.1002/mc.22883

DO - 10.1002/mc.22883

M3 - Article

C2 - 30074279

AN - SCOPUS:85052432152

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

ER -